Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer-oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical knowhow of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

Disclosures to stock exchanges under regulation 30 of SEBI (LODR)

Solara Active Pharma Sciences / Investor Relations / Disclosures to stock exchanges under regulation 30 of SEBI (LODR)

05.10.2018 - Intimation of Credit Rating - 05th October 2018

Transfer of RTA - 13th December 2018

Certified Copy of Order - 20th December 2019

Form 10(C) FOR ESOP Allotment - 24th October 2019

Update on Merger

Encumbrance By Promoters - 4th October 2019

Disclosure on REG 29 SEBI SAST - 3rd October 2019

Stock Exchange Clarification - 14th August 2019

Record Date For Dividend - 19th July 2019

Decleration on Related Party Transaction - 14th June 2019

Annual Secretarial Compliance Certificate for FY ENDED 31.03.2019 - 23rd May 2019

Grant of ESOP 2018 - 16th May 2019

Appointment of Director - 16th May 2019

Diclosure of Large Corporate - 30th April 2019

Change in CIN of Company - 4th January 2019

Alltoment of Convertible Warrants - 8th March 2019

Diclosure of Large Corporate - 30th April 2019

Change in Management- Esop - Regulation 31A

Intimation of Credit Rating - September 25th, 2020

2nd Annual India Ideation Conference - September 25th, 2020

Allotment of 360000 shares - ESOP - September 14th, 2020

Allotment shares pursuant to conversion of warrants - September 1st, 2020

Appointment of Mr. Subash Anand as CFO - August 19th, 2020

Regulatory updates related to Solara’s Cuddalore facility - 23rd June 2020

Solara Corporate Presentation Investor Deck 14th May 2020

Intimation of Effective Date - 1st February 2020

CEO as KMP - 06th February 2020

Grant of Options - 06th February 2020

ESOP Allotment & Grant

Outcome - Scheme Withdrawl - November 11, 2021

Outcome - Revised Scheme of Amalgamation - November 11, 2021

Stock exchange approval for reclassification of sequent

Change in Directorate - August 4, 2021

Paper Publication - Notice of 4th AGM

Paper publication – AGM, Record date & Final dividend

Paper publication – Notice of Board Meeting – August 4, 2021

Press release - July 2, 2021

Promoters pledge release - May 18, 2021

Annual Investor call Conference - May 19, 2021

Large Corporate

Sequent Penems - Wholly Owned Subsidiary - April 28, 2021

Investor Presentation - Solara and Aurore - April 11, 2021

Application for Reclassification of Sequent Scientific Limited - April 8, 2021

Closure of Trading Window for March 31, 2021

Appointment - Mr Subash Anand as ED & CFO - WEF 01.04.2021

Loss of share certificate - 11th January 2021

Press Release - November 01, 2022

Earnings call - Audio Recording Nov 09, 2022

Appointment of Chief Executive Officer

Earnings call - Audio Recording August 04, 2022

Earnings call - Audio Recording April 30, 2022

Resignation of Director - August 04, 2022

Grant of ESOP - August 04, 2022

Appointment of Hariharan as ED and CFO - March 11, 2022

Change in KMP - April 29, 2022

ESOP Allotment - March 09, 2022

Change in KMP - March 09, 2022

ESOP Allotment - February 9, 2022

Change in KMP - February 9, 2022

Postal Ballot Stock Exchange Intimation - January 27, 2023

Press Release - January 30, 2023

Earning Call - Audio Recording - January 25, 2023

Grant of ESOP - January 24, 2023

Press Release - January 27, 2023